Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2015  |  Volume : 28  |  Issue : 1  |  Page : 239-244

Comparison of oral misoprostol and oxytocin for labor induction in prelabor rupture of membranes at term


1 Department of Obstetrics and Gynecology, Faculty of Medicine, Menoufia University, Menoufia, Egypt
2 Department of Obstetrics and Gynecology, El-Mahalla General Hospital, El-Mahalla, Gharbia, Egypt

Correspondence Address:
Shereen M Tayel
Department of Obstetrics and Gynecology, El-Mahalla General Hospital, Tanta University, El-Mahalla, Gharbia
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1110-2098.156001

Rights and Permissions

Objective This study aims to compare the efficacy and safety of oral misoprostol with oxytocin infusion for induction of labor in women with prelabor rupture of membranes (PROM) at term. Background PROM at term is one of the most common complications of pregnancy. It is an important cause of perinatal morbidity and mortality, particularly if it is associated with a prolonged latency period from membranes rupture to delivery. Patients and methods This prospective randomized study included 100 pregnant women admitted to the Department of Obstetrics and Gynecology at El-Mahalla General Hospital presenting with PROM at term. The women were assigned randomly to one of the two equal groups (groups A or B): group A, which received 100 mg oral misoprostol every 4 h for a maximum of three doses, and group B, which received an intravenous infusion of oxytocin starting with a dose of 4 mU/min with an incremental increase of 4 mU/min every 30 min until a maximum dose of 32 mU/min. The primary outcome variable was time from induction to vaginal delivery. The secondary outcomes were mode of delivery, maternal, and neonatal outcomes. Results The study showed that the time intervals from induction to delivery were significantly shorter in the misoprostol group than in the oxytocin group (6.59 ± 1.91 and 9.30 ± 2.58 h, respectively; P < 0.001). Also, there were no significant differences in maternal and neonatal outcomes between both groups. Conclusion Oral misoprostol at a dose of 100 mg every 4 h was not only as successful as oxytocin for labor induction in women presenting with PROM at term but also reduced the duration of labor in nulliparous women. Oral misoprostol was safe in terms of maternal and neonatal outcomes.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1436    
    Printed11    
    Emailed0    
    PDF Downloaded211    
    Comments [Add]    

Recommend this journal